논문 목록
12건 · 최신순-
Evaluating the efficacy of botulinum toxin type a in alleviating neuropsychological symptoms in hemifacial spasm patients.
[OBJECTIVE] To evaluate the efficacy of botulinum toxin type A (BTX-A) in the treatment of neuropsychological symptoms in patients with hemifacial spasm (HFS). [METHODS] Sixty-three HFS patients with neuropsychological symptoms were random…
-
Mapping the Research Landscape of Autologous Fat Grafting in Breast Augmentation.
With increasing demand for cosmetic breast augmentation, autologous fat grafting (AFG) has become increasingly favored due to its natural feel, biocompatibility, and easy accessibility. The hotspot burst analysis revealed that recent resear…
-
Treatment of Neuropsychiatric Symptoms in Parkinson's Disease With Botulinum Toxin A: A 12 week Randomized, Double-Blind, Placebo-Controlled Trial.
ObjectiveThe study aimed to evaluate the impact of Botulinum toxin A (BoNT/A) on neuropsychiatric symptoms in Parkinson's disease (PD) patients.MethodsA total of 125 PD patients and an equal number of age- and gender-matched healthy control…
-
Effects of botulinum toxin type a on nucleotide binding oligomerization domain-like receptor 3 inflammasome in trigeminal ganglion of a rat migraine model.
[BACKGROUND] Botulinum toxin type A (BTX-A) has been used in the prevention and treatment of chronic migraine, but the detailed mechanism was not clear completely. [OBJECTIVE] The effects of BTX-A on nucleotide-binding oligomerization doma…
-
Atrophy Masseter Recovery by Electrical Stimulation Mediated M2-Like Macrophage Polarisation via JAK/PI3K/AKT Pathway.
[BACKGROUND] Atrophy of the masseter muscle can result in an aged facial appearance and diminished chewing function. Electrical stimulation (ES) is known for its ability to facilitate tissue healing and functional recovery, but its precise …
-
Efficacy of Facial Botulinum Toxin A Injections in Alleviating Neuropsychiatric Symptoms in Parkinson's Disease Patients: An Open-Label, Nonrandomized Controlled Trial.
[BACKGROUND AND PURPOSE] Parkinson's disease (PD), a prevalent neurodegenerative disorder characterized by motor impairments, frequently accompanied by neuropsychiatric symptoms that significantly impair daily functioning and quality of lif…
-
Botulinum Toxin A (BTA) for pain and function improvement in osteoarthritis: a systematic review and meta-analysis of clinical efficacy evidence from randomized controlled trials.
[OBJECTIVE] To evaluate the effectiveness of botulinum toxin A injections in improving pain and function in patients with osteoarthritis. [DESIGN] This study systematically searched the PubMed, Web of Science, Embase, Medline, Cochrane Lib…
-
Electrical stimulation prevents condyle and subchondral degeneration following the masseter atrophy.
[OBJECTIVE] There is a strong relationship between masticatory muscle atrophy and condyle degeneration. Although electrical stimulation (ES) is an effective treatment for muscle atrophy, its influence on the underlying condyle is unclear. T…
-
Evaluation of the effect of botulinum toxin A on the physical and mental health of patients with hemifacial spasm.
[BACKGROUND] Hemifacial spasm (HFS) is a debilitating disease characterized by involuntary tonic and clonic contractions of muscles innervated by the facial nerve. Botulinum toxin A (BTX-A) is the first-line option and the most effective me…
-
Effectiveness of microneedle fractional radiofrequency combined with transcutaneous delivery of botulinum toxin in the management of post-acne scars.
[BACKGROUND] Post-acne scars are a common sequela of acne, especially prevalent among young people. Delayed treatment not only affects self-perception of beauty but also affects the mental health of patients. [OBJECTIVE] This study aims to…
-
Botulinum toxin A improves psychological distress in patients with hemifacial spasm.
[OBJECTIVE] This study aimed at assessing mental health in patients with hemifacial spasm (HFS) and determined the effect of botulinum toxin type A (BTX-A) on psychological distress in patients with HFS. [METHODS] Ninety-five HFS patients …
-
The efficacy and safety of botulinum toxin type A in treatment of trigeminal neuralgia and peripheral neuropathic pain: A meta-analysis of randomized controlled trials.
[BACKGROUND] Although recent studies have shown that botulinum toxin-A (BTX-A) has a good analgesic effect on trigeminal neuralgia (TN) and peripheral neuropathic pain (PNP), the quality of evidence is low due to limited data. This meta-ana…